Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pascal Kempers"'
Autor:
Kim M. Smits, Véronique Winnepenninckx, Frank J. P. Hoebers, Eric Thunnissen, Boudewijn Brans, Roy I. Lalisang, Pascal Kempers, Michel Öllers, Ernst-Jan M. Speel, Anne-Marie C. Dingemans, Philippe Lambin, Danielle J. Vugts, Ronald Boellaard, Hugo J.W.L. Aerts, Wouter van Elmpt, Aniek J.G. Even, Ludwig Dubois, Dirk De Ruysscher, Judith van Loon
Publikováno v:
Radiotherapy and Oncology, 122(2), 267-273. Elsevier Ireland Ltd
Radiotherapy and Oncology. Elsevier Ireland Ltd
van Loon, J, Even, A J G, Aerts, H J W L, Öllers, M, Hoebers, F, van Elmpt, W, Dubois, L, Dingemans, A-M C, Lalisang, R I, Kempers, P, Brans, B, Winnepenninckx, V, Speel, E-J, Thunnissen, E, Smits, K M, Boellaard, R, Vugts, D J, De Ruysscher, D & Lambin, P 2016, ' PET imaging of zirconium-89 labelled cetuximab : A phase I trial in patients with head and neck and lung cancer ', Radiotherapy and Oncology . https://doi.org/10.1016/j.radonc.2016.11.020
Radiotherapy and Oncology. Elsevier Ireland Ltd
van Loon, J, Even, A J G, Aerts, H J W L, Öllers, M, Hoebers, F, van Elmpt, W, Dubois, L, Dingemans, A-M C, Lalisang, R I, Kempers, P, Brans, B, Winnepenninckx, V, Speel, E-J, Thunnissen, E, Smits, K M, Boellaard, R, Vugts, D J, De Ruysscher, D & Lambin, P 2016, ' PET imaging of zirconium-89 labelled cetuximab : A phase I trial in patients with head and neck and lung cancer ', Radiotherapy and Oncology . https://doi.org/10.1016/j.radonc.2016.11.020
Background and purpose: PET imaging of cetuximab uptake may help selecting cancer patients with the highest chance of benefit. The aim of this phase I trial was to determine the safety of the tracer (89)zr-cetuximab and to assess tumour uptake.Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9959f75ecca7df97ff4ded68a3ecf60e
https://cris.maastrichtuniversity.nl/en/publications/58d31ff2-271a-4f19-adfa-b2c44087a423
https://cris.maastrichtuniversity.nl/en/publications/58d31ff2-271a-4f19-adfa-b2c44087a423
Autor:
Gonca Çakmak, Pascal Kempers, Günter Oberdörster, Frederik J. van Schooten, Christel Weishaupt, Paul J. A. Borm, Roel P. F. Schins, Erich Jermann
Publikováno v:
Toxicology and Applied Pharmacology, 205(2), 157-167. Elsevier Science
Objective: The current study was designed to test the possible release and bioavailability of polycyclic aromatic hydrocarbons (PAHs) from a set of commercial carbon blacks (CBs) as well as the ability of these PAHs to form bulky DNA adducts. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab304cff110828a890e3ee4647e257cd
https://doi.org/10.1016/j.taap.2004.10.020
https://doi.org/10.1016/j.taap.2004.10.020
